A Cambridge-based company developing gene therapies for rare diseases is laying off more than a third of its workforce.

HHS faces other legal challenges over its workforce cuts. A class-action lawsuit in the U.S. Court for the District of Columbia claims the department relied on “hopelessly error-ridden” data when it ...

Jasper Therapeutics started the year with 64 full-time employees and a robust valuation of more than $320 million. Just seven ...

The number of employees laid off and companies letting people go increased year over year during the first half of 2025.

Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.

FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...

The U.S. Department of Health and Human Services is moving ahead with a plan to cut 10,000 jobs after the Supreme Court ...

Sarepta Therapeutics announced a layoff of 493 employees, including 80 in Franklin County, amid restructuring efforts and ...

Jasper Therapeutics’ dud drug lot has cost half of the biotech's employees their jobs. | Jasper Therapeutics’ dud drug lot ...

Sarepta Therapeutics announced it has laid off more than one-third of its workforce, a drastic cost-cutting move following ...

Trump celebrated when the Supreme Court limited nationwide blocks on his policies, but judges are finding other ways to ...

He called the job “mission impossible.” I recently spoke with a dozen current and former ICE agents and officers about morale ...